Fang C - Search Results

1

Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.

Fang C, Wei XM, Zeng XT, Wang FB, Weng H, Long X. Fang C, et al. BMC Cancer. 2015 Nov 19;15:920. doi: 10.1186/s12885-015-1926-1. BMC Cancer. 2015. PMID: 26585467 Free PMC article.

2

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis.

Zeng H, Fang C, Nam S, Cai Q, Long X. Zeng H, et al. Among authors: fang c. Biomed Res Int. 2014;2014:724209. doi: 10.1155/2014/724209. Epub 2014 Aug 3. Biomed Res Int. 2014. PMID: 25157366 Free PMC article.

3

Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis.

Zhang L, Fang C, Xu X, Li A, Cai Q, Long X. Zhang L, et al. Among authors: fang c. Biomed Res Int. 2015;2015:357485. doi: 10.1155/2015/357485. Epub 2015 Jan 28. Biomed Res Int. 2015. PMID: 25695063 Free PMC article. Review.

4

Association of the pri-miR-124-1 rs531564 polymorphism with cancer risk: A meta-analysis.

Fang C, Zeng H, Li A, Xu X, Long X. Fang C, et al. Mol Clin Oncol. 2015 Jul;3(4):892-896. doi: 10.3892/mco.2015.547. Epub 2015 Apr 17. Mol Clin Oncol. 2015. PMID: 26171202 Free PMC article.

5

Promoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis.

Fang C, Jian ZY, Shen XF, Wei XM, Yu GZ, Zeng XT. Fang C, et al. PLoS One. 2015 Oct 9;10(10):e0140329. doi: 10.1371/journal.pone.0140329. eCollection 2015. PLoS One. 2015. PMID: 26451736 Free PMC article.

6

Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.

Yin C, Fang C, Weng H, Yuan C, Wang F. Yin C, et al. Among authors: fang c. Int Urol Nephrol. 2016 Jul;48(7):1087-95. doi: 10.1007/s11255-016-1281-4. Epub 2016 Apr 11. Int Urol Nephrol. 2016. PMID: 27068818 Review.

7

Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.

Fang C, Wang FB, Li Y, Zeng XT. Fang C, et al. Biomed Pharmacother. 2016 Dec;84:1189-1193. doi: 10.1016/j.biopha.2016.10.006. Epub 2016 Oct 24. Biomed Pharmacother. 2016. PMID: 27788476

8

Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.

Weng H, Li S, Huang JY, He ZQ, Meng XY, Cao Y, Fang C, Zeng XT. Weng H, et al. Among authors: fang c. Sci Rep. 2017 Jan 16;7:40554. doi: 10.1038/srep40554. Sci Rep. 2017. PMID: 28091563 Free PMC article.

9

Association between HIF1A rs11549465 polymorphism and risk of prostate cancer: a meta-analysis.

Li XD, Zi H, Fang C, Zeng XT. Li XD, et al. Among authors: fang c. Oncotarget. 2017 Jul 4;8(27):44910-44916. doi: 10.18632/oncotarget.16489. Oncotarget. 2017. PMID: 28415653 Free PMC article. Review.

10

Genetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis.

Su XJ, Zeng XT, Fang C, Liu TZ, Wang XH. Su XJ, et al. Among authors: fang c. Oncotarget. 2017 May 16;8(20):33953-33960. doi: 10.18632/oncotarget.15424. Oncotarget. 2017. PMID: 28430620 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,543 results

Search Page

Filters